
Please try another search
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong.
Name | Age | Since | Title |
---|---|---|---|
Chunguang Zhang | 56 | 2017 | CEO & Executive Director |
Lai Yin Poon | 53 | 2017 | CFO, Compliance Officer & Executive Director |
Shuguang Zhang | 55 | 2017 | Executive Chairman of the Board |
Yim Yang Chang | 62 | - | Vice Chairman & Director of Shenzhen Huakang and Director of King Grace Company Limited |
Su Bu | 52 | 2024 | Non-Executive Director |
Yujing Zhang | - | 2025 | Executive Director |
Yachun Wang | 41 | 2025 | Independent Non-Executive Director |
Kwok Fai Chow | 52 | 2020 | Independent Non-Executive Director |
Wing Tak Tsui | 56 | 2025 | Independent Non-executive Director |
Ming Xu | 65 | 2024 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review